Gliclazide 80 mg + Metformin 500 mg + Voglibose 0.2 mg SR Tablet – Brands in India, Manufacturer & PCD Franchise (Glizest-MV 80.2)
Gliclazide 80 mg + Metformin 500 mg + Voglibose 0.2 mg (Sustained Release Tab) Tablet
WHO-GMP Manufacturer & PCD Pharma Franchise Supplier in India
Form: Tablet
Class: Second-generation sulphonylurea (Gliclazide-based)
✓ Pan-India Monopoly PCD
✓ 1 Brand Options
Pricing, brochure & monopoly territory within 24 hrs.
Our Gliclazide 80 mg + Metformin 500 mg + Voglibose 0.2 mg (Sustained Release Tab) Tablet Brand Options (1 option)
Trumac Healthcare manufactures and supplies the following Gliclazide 80 mg + Metformin 500 mg + Voglibose 0.2 mg (Sustained Release Tab) Tablet brands for PCD pharma distribution. Click any brand to view full specifications and packaging.
Gliclazide 80 mg + Metformin 500 mg + Voglibose 0.2 mg (Sustained Release Tab) Tablet is manufactured under WHO-GMP-certified conditions by Trumac Healthcare and supplied for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across India. Whether you are a PCD distributor, stockist or retail chemist, our Gliclazide 80 mg + Metformin 500 mg + Voglibose 0.2 mg (Sustained Release Tab) formulation comes with full quality assurance, regulatory documentation and reliable pan-India despatch.
Offered by Trumac Healthcare, a PCD pharma franchise company, available on a monopoly basis – see the general range pharma franchise product list. No franchise fee; minimum first order ₹25,000 – cost and documents.
Gliclazide + metformin + voglibose Brands in India – Glizest-MV 80.2 for PCD Franchise & Wholesale
Looking for gliclazide + metformin + voglibose brands in India? Trumac Healthcare markets gliclazide + metformin + voglibose as Glizest-MV 80.2, made at WHO-GMP certified partner units, on a monopoly PCD franchise basis and as wholesale stock across India. The triple covers fasting and post-meal glucose in one SR tablet; the 0.3 mg voglibose strength is the step-up.
It is part of the cardiac-diabetic PCD franchise (Ecron Life Sciences) range. Trumac Healthcare has worked since 2007 and supplies more than 4000 franchise partners; no franchise fee, minimum first order ₹25,000.
Related brands
- Glizest-MV 80.2 – gliclazide 80 mg + metformin 500 mg + voglibose 0.2 mg SR, 10 x 15
- Glizest-MV 80.3 – voglibose 0.3 mg strength
- Glicatus-M 80/500 – gliclazide + metformin
- Glizest-80 – gliclazide 80 mg
- Full range: cardiac-diabetic PCD franchise (Ecron Life Sciences)
Ways to work with us
- PCD pharma franchise – gliclazide + metformin + voglibose under our brand on a monopoly basis for your area, with visual aids and promotional material
- Wholesale supply – stock for distributors, stockists and hospital suppliers across India, against drug licence and GST
- Own-brand (third-party) enquiries – share the composition, pack and quantity and we will confirm availability and send a quotation
How to start
- Send your requirement on WhatsApp – product, franchise or wholesale, quantity and your area
- Receive the price list and monopoly terms (no franchise fee; minimum first order ₹25,000)
- Confirm the order and pay by NEFT, RTGS or IMPS
- Goods are dispatched once payment reflects, with the docket number for tracking
Questions buyers ask
Which gliclazide + metformin + voglibose brands are available in India for PCD franchise?
Glizest-MV 80.2 from Trumac Healthcare, made at WHO-GMP certified partner units, on a monopoly PCD franchise basis across India.
Do you supply gliclazide + metformin + voglibose wholesale?
Yes, to distributors and stockists with a valid drug licence. Share quantity and location for the rate.
Which division is it part of?
The cardiac-diabetic (Ecron Life Sciences) division, which can be taken alone on monopoly for your district.
Can I get gliclazide + metformin + voglibose under my own brand?
Share your brand name, pack and quantity on WhatsApp and we will confirm availability and send a quotation.
Enquiry: Share your gliclazide + metformin + voglibose requirement – franchise or wholesale, with strength, quantity and location. WhatsApp +91 90416 77932.
Therapeutic Indications
- Type-2 diabetes mellitus
- Adjunct to metformin
- Diabetic patients with vascular risk (gliclazide's antioxidant benefit)
Mechanism of Action
Gliclazide is a second-generation sulphonylurea that stimulates pancreatic beta-cell insulin secretion by closing ATP-sensitive K+ channels (SUR1). It also has antioxidant and antiplatelet effects via free-radical scavenging and reduced platelet aggregation — providing additional benefit in diabetic vascular complications.
Dosage & Administration
- Adults: 1 tablet once daily before breakfast (or as advised)
- Titrate based on glycaemic response
- Maximum 320 mg/day total gliclazide
- MR tablets: swallow whole, do not crush
Side Effects
- Hypoglycaemia
- Weight gain (mild)
- GI upset
- Skin reactions (rare)
- Cholestatic jaundice (rare)
Contraindications
- Type-1 diabetes
- Diabetic ketoacidosis
- Severe hepatic/renal impairment
- Pregnancy and breastfeeding
- Sulphonamide hypersensitivity
Storage
Store below 25°C.
PCD Pharma Franchise for Gliclazide 80 mg + Metformin 500 mg + Voglibose 0.2 mg (Sustained Release Tab) Tablet
- ✓ WHO-GMP certified manufacturing facility
- ✓ Pan-India monopoly distribution rights available
- ✓ Multiple pack sizes: 10 x 15 (Blister)
- ✓ Trade-friendly PTR / PTS margins
- ✓ Free promotional material on request
- ✓ Full DCGI documentation and quality certificates supplied
Trumac Healthcare offers 1 brand option for Gliclazide 80 mg + Metformin 500 mg + Voglibose 0.2 mg (Sustained Release Tab) Tablet — each available in different pack sizes with trade-friendly margins. View the brand-specific pages below for detailed specifications, MRPs and packaging options.
For PCD franchise opportunities, monopoly distribution rights, or third-party contract manufacturing of Gliclazide 80 mg + Metformin 500 mg + Voglibose 0.2 mg (Sustained Release Tab) Tablet, contact our business development team. WhatsApp +91 9041677932 or email info@trumachealthcare.net.
Frequently Asked Questions
Who is the manufacturer of Gliclazide 80 mg + Metformin 500 mg + Voglibose 0.2 mg (Sustained Release Tab) Tablet?
Trumac Healthcare is a WHO-GMP certified manufacturer of Gliclazide 80 mg + Metformin 500 mg + Voglibose 0.2 mg (Sustained Release Tab) Tablet in India. We supply our own brand range (see brand options above) and also offer third-party contract manufacturing for PCD distributors.
Is Gliclazide 80 mg + Metformin 500 mg + Voglibose 0.2 mg (Sustained Release Tab) Tablet available for PCD pharma franchise on monopoly basis?
Yes. We offer Gliclazide 80 mg + Metformin 500 mg + Voglibose 0.2 mg (Sustained Release Tab) Tablet for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across all districts of India. Contact our business development team for pricing and territory availability.
What pack sizes are available for Gliclazide 80 mg + Metformin 500 mg + Voglibose 0.2 mg (Sustained Release Tab) Tablet?
Available pack sizes include: 10 x 15 (Blister).
What is the MRP / trade price for Gliclazide 80 mg + Metformin 500 mg + Voglibose 0.2 mg (Sustained Release Tab) Tablet?
MRPs range from ₹2380 to ₹2380 across our brand variants. Trade-friendly PTR/PTS margins available on request — WhatsApp +91 9041677932 for current rates.
How do I place an order or franchise enquiry?
WhatsApp +91 9041677932 or email info@trumachealthcare.net with your enquiry. Our team will revert within 24 hours with full pricing, brochure and franchise terms.
Ready to start your PCD franchise for Gliclazide 80 mg + Metformin 500 mg + Voglibose 0.2 mg (Sustained Release Tab) Tablet?